Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN106543144A reveals a safer industrial process for Dabigatran Etexilate. Achieve high purity and cost reduction in pharmaceutical manufacturing with scalable solutions.
Novel pyridazinone-containing norcantharidin derivative synthesis via 1,3-dipolar cycloaddition. Offers high purity pharmaceutical intermediates with optimized supply chain reliability.
Patent CN117263870A details high-yield Resmetirom intermediate III synthesis with reduced cost and environmental impact for global pharmaceutical supply chains.
Novel Cu-catalyzed method for Tazobactam Sodium synthesis. Delivers safer, scalable, and cost-effective production solutions for global pharmaceutical supply chains and procurement teams.
Novel synthetic route for 8-azacoumarins offering high yield and solubility for pharma supply chains. Scalable process from patent CN106810560A.
Patent CN111484533B discloses novel Ir-SpiroPNP catalysts achieving 99.8% ee in dialkyl ketone hydrogenation, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN117603100B reveals a green one-pot synthesis route offering significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN111138492B details a high-yield Brigatinib synthesis avoiding column chromatography. This report analyzes cost reduction and supply chain reliability for API manufacturing.
Patent CN104817484A reveals metal-free 2-indolone synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN102010455B reveals a novel Decitabine synthesis avoiding isomer separation. High purity >99.85% via Barton-McCombie deoxygenation for cost-effective manufacturing.
Patent CN108586211B reveals a cost-effective Pd-catalyzed decarboxylative coupling method for 1,1-diarylethene derivatives, offering significant supply chain advantages.
Novel asenapine preparation method using Red-Al ensures safety and scalability. Ideal for pharmaceutical intermediate supply chains seeking cost-effective solutions globally.
Patent CN103113290A details a cost-effective Pd/C catalyzed route for 3-methylaminopiperidine, offering significant supply chain advantages for fluoroquinolone producers.
Advanced Pd-Cu catalytic method for phenanthrene intermediates. Enhances yield and supply chain stability for pharmaceutical manufacturing partners globally.
Novel solvent system reduces toxic Impurity H in Ceftazidime synthesis, ensuring high purity and supply chain reliability for global pharmaceutical manufacturers.
Patent CN108640945B reveals a novel Ru/Ir-catalyzed direct C-H alkynylation of amides. This method eliminates directing groups, offering cost-effective routes for high-purity pharmaceutical intermediates.
Novel hydroxylamine hydrochloride route for Lafutidine improves purity to 99.88% and reduces impurities significantly for reliable pharmaceutical intermediates supply chain stability.
Novel copper-catalyzed process enhances yield and reduces costs for pharmaceutical intermediates manufacturing ensuring supply chain reliability and high purity standards.
Novel chiral catalytic route for tenofovir analogs offering high enantioselectivity and cost efficiency for global pharmaceutical supply chains and manufacturing partners.
Patent CN113173951B details a ZrCl4-catalyzed route to phosphorylated dihydropyrimidinones, offering high yields and mild conditions for reliable pharmaceutical intermediate supply.